The data underlying this study have been uploaded to Dryad and are accessible using the following DOI: [10.5061/dryad.5hqbzkh2j](https://doi.org/10.5061/dryad.5hqbzkh2j).

Introduction {#sec001}
============

Extracerebral tumors are most typically benign, but some have malignant tumor growth characteristics, such as pushing, compressing, and even eroding adjacent normal brain tissue. Surgical treatment of these tumors is effective, but the prognosis depends largely on the location of the tumor and the degree of brain protection. The correct identification of brain functional areas during surgery helps surgeons to reduce the damage to normal brain tissue. Currently, 3D imaging technology can identify the relationship between extracerebral tumors and brain tissue by determining anatomical locations, which has provided great convenience for surgeons to make preoperative plans \[[@pone.0230754.ref001]\].

However, it is difficult to accurately identify brain areas, especially the motor function regions, because they are often deformed by the tumor. The solution is to use a neural navigation system, an anesthesia-arousal technique, and intraoperative electrophysiological monitoring during the operation. However, the above technologies are expensive and complex and thus cannot be performed in primary units. Here, we provide a cheap and simple alternative to localize brain functional areas covered by extracerebral tumors, which can be achieved in any units.

Materials and methods {#sec002}
=====================

Study design and study population {#sec003}
---------------------------------

All patients were older than 5 years per the requirements of FreeSurfer \[[@pone.0230754.ref002]\]. The patients underwent magnetic resonance imaging (MRI) examination at the Hospital of Chengdu University of Traditional Chinese Medicine from June 2018 to July 2019 for diagnosing extracerebral intracranial tumors. Patients with severe peritumor edemas were excluded.

The Hospital of Chengdu University of Traditional Chinese Medicine Research Ethics Committee approved the study. All procedures involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards, and informed consent was not required because of the retrospective nature of this study.

Data acquisition {#sec004}
----------------

Twenty-three patients with extracerebral tumors were selected, and they underwent nonenhanced T1-weighted (T1W) 3D fast spoiled gradient recalled (FSPGR) sequence MRI scans. The data were acquired on a 3.0 Tesla MRI scanner (GE Discovery MR750, America) using a 32-channel head or 8-channel standard joint head and neck coil. The scan parameters were as follows: TR/TE, 8.2 s/3.2 s; slice thickness, 0.5mm; FOV, 240 mm×240 mm; matrix, 256 mm×256 mm; flip angle, 12°; 312 sections. The scans were performed mainly in the axial view, but some cases had scans performed in the coronal view.(URL: <https://datadryad.org/stash>, doi:[10.5061/dryad.5hqbzkh2j](https://doi.org/10.5061/dryad.5hqbzkh2j)) (temporary link: <https://datadryad.org/stash/share/kjhTMQ7WsqzkOxnqsCAeAd0466sbUNU-0M1ElOfxpuM>).

Software {#sec005}
--------

The 3D Slicer (<http://www.slicer.org>, Surgical Planning Laboratory, Harvard University, Boston, MA, USA, version 4.10.2) and FreeSurfer (<http://www.freesurfer.net>, MIT Health Sciences & Technology, and Massachusetts General Hospital, USA, version stable 6.0) software used in this study were free and open source. 3D-Slicer is available on multiple operating systems (Windows-64 bit, Linux, and MacOSX) and is used by surgeons for performing interactive segmentation, visualizing 3D medical images, and guiding therapy \[[@pone.0230754.ref003],[@pone.0230754.ref004]\]. FreeSurfer requires Linux or MacOSX, either natively or a Windows-based virtual machine and is used mainly for the analysis and visualization of structural and functional neuroimaging data from patients with functional neurological disorders (FNDs) of the brain without structural damage, such as anxiety/depression, obsessive-compulsive disorder (OCD), epilepsy, posttraumatic brain syndrome (PTS) and so on \[[@pone.0230754.ref005]\]. For the hardware platform, we used a laptop with a 2.6 GHz Intel Core i7-9750 CPU, 16 GB RAM, and a 4GB NVIDIA GeForce GTX 1650 GPU running Windows 10 Home Edition 64-bit Version for 3D Slicer. Another desktop computer with a 3.2 GHz Intel Core i5-9750 CPU, 8 GB RAM, and an Integrated Graphics 620 GPU running Ubuntu 16.04 LTS 64-bit Version for FreeSurfer.

Dcm2nii is a part of the MRIcroN software (<https://www.nitrc.org/projects/mricron>) that can convert original DICOM data into the NIfTI or another medical image format, reducing the duration for importing data for operation \[[@pone.0230754.ref006]\].

Fill between slices and GrowCut segmentation in 3D slicer {#sec006}
---------------------------------------------------------

Fill between slices is a function of the Segment Editor module in 3D Slicer, which can perform a complete segmentation on selected slices using any editor effect. GrowCut Segmentation is an interactive segmentation approach that is based on the idea of a cellular automaton and is another function of the Editor module. Egger et al. \[[@pone.0230754.ref007],[@pone.0230754.ref008]\] indicate that GrowCut is a better way to perform tumor segmentation, as it is semiautomated, saves time, reduces operator effort and produces a more accurate segmentation than manually outlining the tumor slice by slice.

Volume clip with model and swiss skull stripper in 3D slicer {#sec007}
------------------------------------------------------------

Volume clip with model is a module of the VolumeClip extension, which needs to be installed in the Extensions Manager. This module can remove the volume contents inside or outside the selected surface model. Swiss Skull Stripper is another module that must be installed in Extensions Manager that can strip the scalp and skull from the brain, but a template (Atlas Image and Atlas Mask) is needed as a reference image and can be downloaded from the 3D Slicer website (<https://www.slicer.org/wiki/Documentation/Nightly/Modules/SwissSkullStripper>).

Recon-all command in FreeSurfer {#sec008}
-------------------------------

Recon-all (<http://surfer.nmr.mgh.harvard.edu/fswiki/recon-all>) is a standard and simple command in FreeSurfer that can automatically process whole-brain segmentation without human intervention step by step. Additionally, if a phase of the brain segmentation fails, the user can continue processing from that phase with the "Recon-all-X" command. The results produced by Recon-all include eight directories; in our study, we only needed the label, mri, and surf directories. The processing time depends on the computer configuration.

Processing steps {#sec009}
----------------

The 3D Slicer software was used to remove the tumor manually, and brain segmentation was automatically performed according to the following steps in FreeSurfer ([Fig 1](#pone.0230754.g001){ref-type="fig"}):

-   The 3D-T1W FSPGR DICOM data were dragged and dropped into the Dcm2nii software, converting the DICOM data to the SPM8 (3D NIFT) format. A new set of data, prefixed with the letters CO (remove neck), were generated and selected.

-   The Nii data were loaded into 3D Slicer. Of particular note, different sequences can be overlaid only if they are in the same space. In this step, the "Centered" must be checked or the volume information section in the Volume module must be modified to ensure the standard spatial position.

-   An axial image was chosen and magnified to draw a boundary around the tumor. The Fill between slices or GrowCut Segmentation function was used to label the tumor and then show the tumor model in a 3D view. After inspection of the model, morphological operations from Segment Editor such as dilation, erosion, island removal, Scissors, and smoothing were used for postprocessing.

-   The Segmentation module was used to export the tumor label to the model, and the Volume clip with model module was used to remove the tumor from the Nii data. Unchecking the "Clip outside" option and inputting a value of "0" (the typical background voxel brightness in MRI) in the pipeline box then generated a new set of Nii data without the tumor.;

-   After loading the new Nii data into FreeSurfer, the "Recon-all" command was run to automate the segmentation of whole-brain structures; the duration of this operation depends on the machine configuration. Another traditional segmentation method uses the Swiss Skull Stripper module to strip the skull and scalp from the brain and then conduct a 3D reconstruction.

-   According to the different needs of the brain templates, we can chose the different kind of files with the suffixes pial, anno and mgz. In our case, lh/rh.pial, lh/rh.aparc.anno and the original 3D-T1W Nii data files were selected and imported into 3D Slicer in sequence. Then, imported the aparc+aseg.mgz file and selected "Label Map" and "Centered" and the option to show "FreeSurferLabels".

-   If a partial brain defect was found in the brain model, it was repaired in 3D Slicer with information from the unaffected side of the brain. Finally, the tumor label was reloaded and automatically superimposed onto the brain model to fuse the tumor and brain models.

![Technology Roadmap.](pone.0230754.g001){#pone.0230754.g001}

Model evaluation {#sec010}
----------------

Subjective evaluation was conducted according to clinical requirements. The cerebral cortex model and 3D volume-rendered images of the patients were both evaluated simultaneously by 2 senior and 2 younger neurosurgeons, and scored according to evaluation criteria ([Table 1](#pone.0230754.t001){ref-type="table"}). If the scores were inconsistent, the final scores were determined through negotiation ([Table 2](#pone.0230754.t002){ref-type="table"}). The two groups of scores were tested using two-tailed Wilcoxon signed-rank test. SPSS (version 17.0; SPSS Inc., Chicago, Illinois, USA) was used for analysis, and a p value\<0.05 was considered statistically significant.

10.1371/journal.pone.0230754.t001

###### Evaluation criteria ratings.

![](pone.0230754.t001){#pone.0230754.t001g}

  Scores   Quality   Interfere with the Scale
  -------- --------- ---------------------------------------------------------------------------------------------------------------------------------------
  3        Good      The sulci and gyri can be clearly identified, and the functional area of the brain where the tumor is located can be identified
  2        Medium    The sulci and gyri can be clearly identified, but the functional area of the brain where the tumor is located cannot be identified
  1        Bad       The sulci and gyri cannot be clearly identified, and the functional area of the brain where the tumor is located cannot be identified

10.1371/journal.pone.0230754.t002

###### Summary of the results.

![](pone.0230754.t002){#pone.0230754.t002g}

  Sub   Tumor Classification        Sex      Age   Tumor size (cm^3^)   Brain Model Defect   Time (h)   Freesurfer Model Score (Senior/Younger)   3D Slicer Model Score (Senior/Younger)
  ----- --------------------------- -------- ----- -------------------- -------------------- ---------- ----------------------------------------- ----------------------------------------
  1     Pituitary adenoma           Female   18    9.086                No defect            9.657      3/3                                       3/3
  2     Pituitary adenoma           Female   41    11.835               No defect            9.865      3/3                                       3/3
  3     Pituitary adenoma           Female   35    10.569               No defect            9.946      3/3                                       3/3
  4     Pituitary adenoma           Female   30    8.357                No defect            9.609      3/3                                       3/3
  5     Pituitary adenoma           Female   45    9.268                No defect            8.959      3/3                                       3/3
  6     Pituitary adenoma           Male     69    8.542                No defect            9.257      3/3                                       3/3
  7     Pituitary adenoma           Male     75    10.289               No defect            9.268      3/3                                       3/3
  8     Acoustic neuroma            Male     36    9.039                No defect            9.454      3/3                                       3/2
  9     Acoustic neuroma            Male     48    10.261               No defect            9.658      3/3                                       2/2
  10    Acoustic neuroma            Male     70    16.078               No defect            8.579      3/3                                       2/2
  11    Acoustic neuroma            Female   68    8.661                No defect            8.783      3/3                                       2/2
  12    Acoustic neuroma            Female   54    8.198                No defect            9.236      3/3                                       2/2
  13    Trigeminal schwannoma       Male     28    15.358               No defect            10.258     3/3                                       3/2
  14    Parafalcine meningioma      Male     45    23.587               Partial defect       9.529      2/2                                       2/1
  15    Convexity meningioma        Female   70    74.154               Partial defect       10.263     2/2                                       2/1
  16    Parafalcine meningioma      Female   53    5.838                No defect            8.257      3/3                                       2/1
  17    Sella meningioma            Male     53    8.404                No defect            8.314      3/3                                       2/2
  18    Sella meningioma            Female   38    9.230                No defect            8.693      3/3                                       2/2
  19    Tentorial meningioma        Female   56    3.673                No defect            8.563      3/3                                       1/1
  20    Sphenoid ridge meningioma   Male     65    25.786               Partial defect       9.458      2/1                                       1/1
  21    Sphenoid ridge meningioma   Male     49    19.258               Partial defect       9.568      2/1                                       1/1
  22    Craniopharyngioma           Female   48    16.561               No defect            9.244      3/3                                       3/2
  23    Craniopharyngioma           Male     44    15.854               No defect            10.059     3/3                                       3/2

Illustrative cases {#sec011}
------------------

### Sub6 and Sub8 {#sec012}

A 69-year-old man who had decreased visual acuity and bitemporal hemianopia for 3 months and a 36-year-old man with 2-months progressive hearing loss were admitted to our department. They were diagnosed having pituitary tumor ([Fig 2A](#pone.0230754.g002){ref-type="fig"}) and acoustic neuroma ([Fig 3A](#pone.0230754.g003){ref-type="fig"}) respectively according to the MRI-T1-3D-FSPGR examination. The tumors were labeled and removed by 3D Slicer (Figs [2B/2C](#pone.0230754.g002){ref-type="fig"} and [3B/3C](#pone.0230754.g003){ref-type="fig"}), and the brain segmentation was successfully operated by FreeSurfer (Figs [2D](#pone.0230754.g002){ref-type="fig"} and [3D](#pone.0230754.g003){ref-type="fig"}). The gyrus rectus is clearly observed compressed by the pituitary tumor ([Fig 2E and 2F](#pone.0230754.g002){ref-type="fig"}) and the junction of cerebellar hemisphere and brainstem are compressed by acoustic neuroma in the color brain model ([Fig 3E and 3F](#pone.0230754.g003){ref-type="fig"}). These models provided more intuitive information to the surgeons than conventional 3D VR images.

![(Sub 6, Pituitary adenoma).\
These screenshots present the segmentation results in a coronal (A-C) slice for the automatic GrowCut tumor segmentation algorithm in 3D Slicer and automatic brain segmentation in FreeSurfer. The bilateral gyrus rectus was pushed and deformed by the tumor (D-F).](pone.0230754.g002){#pone.0230754.g002}

![(Sub 8, Right Acoustic neuroma).\
These images depict the segmentation results in an axial (A-C) slice for manual tumor segmentation in 3D Slicer and automatic segmentation of brain structures without the tumor in FreeSurfer. The brainstem and cerebellum were pushed by the tumor (D-F).](pone.0230754.g003){#pone.0230754.g003}

### Sub15 {#sec013}

A 70-year-old woman with giant convexity meningioma in the motor area had a limb movement disorder for 6 months ([Fig 4A](#pone.0230754.g004){ref-type="fig"}). The tumor was labeled and removed by 3D Slicer ([Fig 4B and 4C](#pone.0230754.g004){ref-type="fig"}). The brain tissue was segmented with the method we provide ([Fig 4D](#pone.0230754.g004){ref-type="fig"}). The gyrus around the tumor was segmented by FreeSurfer ([Fig 4E](#pone.0230754.g004){ref-type="fig"}) and repaired in 3D Slicer with reference to the opposite normal brain tissue ([Fig 4F and 4G](#pone.0230754.g004){ref-type="fig"}). The adjacent anterior central gyrus and posterior central gyrus are deformed by tumor extrusion, but they can still be identified after FreeSurfer segmentation ([Fig 4F](#pone.0230754.g004){ref-type="fig"}). After removing the tumor during the operation, the surgeon can identify the regions of the brain that have been deformed according to the color brain model ([Fig 4H](#pone.0230754.g004){ref-type="fig"}).

![(Sub 15, left convexity meningioma).\
These images show the segmentation results in an axial slice for manual tumor segmentation in 3D Slicer (A-C) and automatic segmentation for the whole brain in FreeSurfer (D). The model was partially damaged (E), and the defect was repaired with information from the unaffected side of the brain (F). The postcentral, precentral, and superior frontal gyri and the caudal middle frontal cortex were pushed by the tumor (G). According to the above partitions, the "real" lobes can be identified after tumor removal (H).](pone.0230754.g004){#pone.0230754.g004}

Results {#sec014}
=======

A total of 19 cases successfully underwent brain segmentation without errors. Partial gyri defects were found in 4 cases and repaired with information from the unaffected side of the brain in 3D Slicer. The detailed results of our study are presented in [Table 2](#pone.0230754.t002){ref-type="table"}. The total time consumed was approximately 9.325±0.586 hours. Both senior and younger neurosurgeons agreed that the brain model created by FreeSurfer was better and had more easily identifiable substructures (p\<0.01).

Discussion {#sec015}
==========

Extracerebral intracranial tumors are usually benign \[[@pone.0230754.ref009]\] and have a clear interface with the surrounding brain tissue; complete removal of the tumor while minimizing neurological deficits should be pursued, especially for tumors in functional areas of the brain. 3D medical imaging processing software such as 3D Slicer, ITK-SNAP \[[@pone.0230754.ref010]\], and Mimics \[[@pone.0230754.ref011]\], can be used to locate the tumor and perform simulated surgery, but it is difficult to accurately distinguish the brain regions around the tumor only by the naked eye. At present, the solution to this problem is to use an intraoperative navigation system \[[@pone.0230754.ref012]\] combined with anesthesia-arousal techniques \[[@pone.0230754.ref013]\] to accurately identify the functional areas of the brain.

Neurosurgery relies on stereospecific neuronavigation devices for real-time and accurate positioning, which play a central role in modern neurosurgery. Although the methods mentioned above are accurate and effective, the equipment needed is complex and expensive, and doctors are required to master the complex operating procedures and maintain strict control of anesthesia depth. Hence, it is not a technology that can be carried out in hospitals at all levels, especially in developing countries \[[@pone.0230754.ref014]\]. Locating intracranial lesions accurately without this equipment is a difficult and urgent problem that needs to be solved.

The algorithms involved in brain tumor segmentation are varied and complex. Chang et al. \[[@pone.0230754.ref015]\] developed a deep learning algorithm to automatically segment gliomas, but this is a difficult technique for clinicians with no computer background and is therefore difficult to widely implement. A simpler and more practical segmentation method is needed. 3D Slicer is simple to operate, easy to learn and can accurately locate the lesion site, calculate the lesion volume, simulate the surgical path, and support virtual reality (VR) technology. It also has a variety of powerful tumor profiling tools \[[@pone.0230754.ref004]\]. Sina Application is a free medical image projection software that supports the Android system. The image can be projected onto the patient\'s head to accurately position intracranial lesions in real-time \[[@pone.0230754.ref016]\].

Combining 3D Slicer and the Sina software, Chen et al. \[[@pone.0230754.ref003]\] successfully performed the accurate localization of intracranial lesions and observed the relationship between the lesions and peripheral blood vessels. The above study indicates that even without stereotactic neuronavigation equipment, 3D Slicer combined with the Sina software can still provide neurosurgeons with a large amount of 3D information for the lesion and simulate reasonable surgical plans before surgery, which can greatly reduce surgical complications and improve the benefits to the patients. However, surgeons can still only locate intracranial lesions and determine their relationship with adjacent tissues based on anatomical maps, and the results will inevitably have some errors.

FreeSurfer is another free program that performs segmentation of healthy brain structural and functional areas \[[@pone.0230754.ref002]\]. The generated data can be imported into 3D Slicer for localizing brain functional areas in the vicinity of intracranial tumors. However, according to the handbook, FreeSurfer is not suitable for segmenting a brain with an abnormal structure \[[@pone.0230754.ref002]\]. In order for FreeSurfer to construct cerebral cortex and deep white matter models, the complete gray-matter interface is required. For general neuroscience studies, this problem is irrelevant; however, the presence of intracranial lesions results in damage to the gray-matter interface. Therefore, for such diseases, FreeSurfer cannot directly segment the brain model, making the software results unsuitable for clinical neurosurgeons. Therefore, up to now, this software has only been used in the field of functional neurological diseases, such as hemifacial spasm (HFS) \[[@pone.0230754.ref017]\], epilepsy \[[@pone.0230754.ref018]\] and posttraumatic head syndrome (PTSD) \[[@pone.0230754.ref019]\].

The algorithm of FreeSurfer is very complex; briefly, its processing includes motion correction and averaging \[[@pone.0230754.ref020]\] of multiple volumetric T1-weighted images (when more than one is available), removal of nonbrain tissue using a hybrid watershed/surface deformation procedure \[[@pone.0230754.ref021]\], automated Talairach transformation, and segmentation of the subcortical white matter and deep gray matter volumetric structures. In our study, we proposed a new, simple method to remove tumors from the T1W 3D-FSPGR data of patients with extracerebral tumors via a virtual operation by setting the values corresponding to the tumor to "0". The interface between the normal brain tissue and the tumor is artificially divided. Then, the new data are imported into FreeSurfer to automatically segment the brain structure. FreeSurfer can automatically identify the \"0\" regions as nonbrain tissue to be excluded.

The result of this method is feasible, and although some brain tissue defects may occur (mostly in cases involving supratentorial extracerebral tumors), 3D Slicer can be used to repair them. Sub 15 is a typical case with a giant convexity meningioma in the motor area ([Fig 4](#pone.0230754.g004){ref-type="fig"}). After removing the tumor during the operation, the surgeon can identify the regions of the brain that have been deformed according to the color brain model. This method does not require mastery of complex computer languages and operating procedures, allowing even regular residents to operate the software.

Based on the procedures from Chen et al. \[[@pone.0230754.ref003]\], our study innovatively utilizes 3DSlicer and FreeSurfer software to break through the conventional limitations of FreeSurfer; our technique can not only realize the accurate positioning of intracranial lesions and brain functional areas in real-time but also assist physicians in assessing the relationship between the tumor and peripheral brain regions. Both the younger and senior physicians agreed that the color brain model created from our method was more easily recognizable and understood than the traditional single-tone brain model. In addition, the above software is free, can be run flexibly at all levels of units and is not restricted by expensive medical equipment. Moreover, the STL (stereolithography) file format created by 3D Slicer can be used to 3D print brain models, aiding AR/VR virtual surgery and VR surgical teaching and providing more accurate 3D information for increasing the confidence of surgeons, allowing them to make better surgical plans and better train young surgeons, as well as shortening their learning curves \[[@pone.0230754.ref001]\].

There are several future works in development. We plan to conduct further multimodal image fusion studies based on the current research; for example, the integration of diffusion tensor imaging (DTI) into the 3D brain model created by FreeSurfer could lead to a more accurate judgment of the relationship between the tumor and surrounding nerve fiber bundles and help surgeons better protect white matter tracts (WMT) \[[@pone.0230754.ref022],[@pone.0230754.ref023]\]. In addition, vascular (CTA/MRA, MRV) and skull (CT) models can be fused with the FreeSurfer models, and combined with Sina, these models could help surgeons make more accurate preoperative plans and yield more benefit for surgeon training and patient education. 3D printing is a further derivation of VR technology, and color 3D printing is more suitable for illustrating functional areas of the brain, while its costs need to be reduced and its efficiency needs to be improved \[[@pone.0230754.ref024]\].

In summary, the methods we have provided can be used by surgeons as a cheap and easy way to identify the "real" relationship between the extracerebral intracranial lesion and adjacent brain tissue before surgery and improve preoperative planning in any unit.

Conclusions {#sec016}
===========

Our approach for segmenting extracerebral intracranial tumors is facilitated, requires no complex programming, and can be utilized even by doctors without a computer background independently. The resulting clear 3D color structure image provides additional assistance to surgeons for obtaining more accurate information and making better preoperative planning. Neurosurgery is a subject closely integrated with computer and artificial intelligence. Proficiency in computer-related medical technology is an inevitable skill for neurosurgeons to develop \[[@pone.0230754.ref025]\].

Limitations {#sec017}
===========

Our subjects were limited to those with extracerebral tumors with no significant edema, brain tissue deformations only by tumor compression, and a lack of brain defects. Cases involving tumors with significant edema or in the intracerebral region tend to present with destruction of the white or gray matter structure, and thus this segmentation method is no longer applicable. Moreover, our case involves a small sample size, and future studies will require a larger group of patients. Additionally, data processing in FreeSurfer is time consuming, inefficient and may even produce errors that require human intervention. Our method can only provide anatomical segmentation of brain tissue according to different brain structure templates.

Supporting information {#sec018}
======================
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1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

Reviewer \#2: Partly

\*\*\*\*\*\*\*\*\*\*

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: I Don\'t Know

Reviewer \#2: N/A

\*\*\*\*\*\*\*\*\*\*

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: No

Reviewer \#2: No

\*\*\*\*\*\*\*\*\*\*

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: No

Reviewer \#2: No

\*\*\*\*\*\*\*\*\*\*

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: There is a lot of statistics hidden in the software that is not addressed in the methods. To my impression, these are pre-processed algorithms provided by the manufacturers, which are not clearly presented in the methods section, other than that they are being applied.

The manuscript in my opinion serves best the purpose of a methods paper. However, there is no other validation of the proposed method of inquiry other than the visual confirmation of realistic segmentation by the algorithm based on clinicians estimation.

Throughout the paper there needs to be attention for the use of grammar and typos.

The real valor of these segmentation algorithms would be in the application of pre-surgical planning for tumors with a lot of edema of intraparenchymal invasion. The manuscript would benefit with regard to scientific and translational impact if the authors could demonstrate any feasibility of these algorithms or the applied software to tackle these hurdles.

Reviewer \#2: This manuscript is a methodology paper explaining the methods for reconstruction of MRI data for anatomic neurosurgical planning using free, open-source software. This methodology is useful for the field of neurosurgery, and is both less technically challenging and less financially restrictive than other options. This method may potentially be a useful addition to the neurosurgical toolbox, but I find a number of problems with this submission. Primarily, the data used to generate their figures is not made available, and as such their figures cannot be reproduced to validate their methodology. Secondarily, this article could benefit from a significant overhaul by a professional, English-language scientific editor. There are sections of the manuscript where the meaning of the authors is unclear, there are multiple incomplete sentences, and innumerable other grammatical and syntactical errors.

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: Yes: Rutger Balvers

Reviewer \#2: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.

10.1371/journal.pone.0230754.r002

Author response to Decision Letter 0

14 Jan 2020

Dear Editor,

We have studied the valuable comments from you, the assistant editor and reviewers carefully, and tried our best to revise the manuscript. We want to upload all the patient data, but because the Dicom/Nii data of all the patients is too large, we can only upload part of the patient data to verify the repeatability of our study. The point to point responds to the reviewer's comments are listed as following:

Responds to the reviewer's comments:

Reviewer 1

Comment 1: There is a lot of statistics hidden in the software that is not addressed in the methods. To my impression, these are pre-processed algorithms provided by the manufacturers, which are not clearly presented in the methods section, other than that they are being applied.

Response: According to the reviewer's comment, we have added the software instructions, the algorithm of FreeSurfer is very complex; briefly, its processing includes motion correction and averaging of multiple volumetric T1-weighted images (when more than one is available), removal of nonbrain tissue using a hybrid watershed/surface deformation procedure, automated Talairach transformation, and segmentation of the subcortical white matter and deep gray matter volumetric structures. As a clinician, it is difficult to master the running algorithm of the software, and the official website does not mention too much. We were inspired by the simple calculation process provided by the official website. For the extracerebral intracranial tumors without serious peripheral edema, the boundary was clearly separated from the normal brain tissue. After the tumor was artificially labeled and removed, the interface between the normal brain tissue and the tumor is artificially divided. Then, the software could successfully carry out automatic brain tissue segmentation according to its original algorithm.

Comment 2: The manuscript in my opinion serves best the purpose of a methods paper. However, there is no other validation of the proposed method of inquiry other than the visual confirmation of realistic segmentation by the algorithm based on clinicians estimation.

Response: Thank you for your suggestion. We divided the definition of the sulci and gyri into three levels, the cerebral cortex model created by FreeSurfer and 3D volume-rendered images created by 3D Slicer were both evaluated simultaneously by 2 senior and 2 younger neurosurgeons, and scored according to subjective evaluation criteria. The two groups of scores were tested using a two-tailed Wilcoxon signed-rank test. SPSS was used for analysis, both senior and younger neurosurgeons agreed that the brain model created by FreeSurfer was better and had more easily identifiable substructures (p\<0.01).

Comment 3: Throughout the paper there needs to be attention for the use of grammar and typos.

Response: Thank you for your careful work. We have submitted the original manuscript to the English translation company for revision.

Comment 4: The real valor of these segmentation algorithms would be in the application of pre-surgical planning for tumors with a lot of edema of intraparenchymal invasion. The manuscript would benefit with regard to scientific and translational impact if the authors could demonstrate any feasibility of these algorithms or the applied software to tackle these hurdles.

Response: Thank you for your advice. However, at present, there is no algorithm that can automatically segment the normal brain tissue from patients with brain tumors. Not just intracranial tumors cannot be segmented, but also extracranial tumors with severe peripheral edema also could not be segmented, because the blood brain barrier has been broken and gray matter boundary is not clear, the task of brain segmentation cannot be completed by Freesurfer software. We have tried to use Freesurfer software to segment the extracranial tumors with severe edema and intracranial tumors, unfortunately, it can only get a defect model of brain tissue or even produce software errors that prevent brain segmentation. Therefore, the proposed method is currently only applicable to brain segmentation of extracranial tumors. Nevertheless, this method can still provide useful information for clinicians, especially when the extracranial tumor is located in a motor and language function areas.

Reviewer 2

Comment 1: Primarily, the data used to generate their figures is not made available, and as such their figures cannot be reproduced to validate their methodology.

Response: According to the reviewer's comment, we want to upload all the patient data, but because the Dicom/Nii data of all the patients is too large, we can only upload part of the patient data to verify the repeatability of our study.

Comment 2: Secondarily, this article could benefit from a significant overhaul by a professional, English-language scientific editor. There are sections of the manuscript where the meaning of the authors is unclear, there are multiple incomplete sentences, and innumerable other grammatical and syntactical errors.

Response: Thank you for your careful work. We have submitted the original manuscript to the English translation company for revision.

###### 

Submitted filename: Response to Reviewers.docx

###### 

Click here for additional data file.

10.1371/journal.pone.0230754.r003
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A New Simple Brain Segmentation Method for Extracerebral Intracranial Tumors

PLOS ONE

Dear Mrs dongdong,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

We would appreciate receiving your revised manuscript by Mar 19 2020 11:59PM. When you are ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled \'Manuscript\'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Jonathan H Sherman

Academic Editor

PLOS ONE

\[Note: HTML markup is below. Please do not edit.\]

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#2: All comments have been addressed

Reviewer \#3: All comments have been addressed

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#2: Partly

Reviewer \#3: Partly

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#2: N/A

Reviewer \#3: I Don\'t Know

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#2: Yes

Reviewer \#3: No

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#2: Yes

Reviewer \#3: No

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#2: (No Response)

Reviewer \#3: The manuscript would benefit from revision by an English language editor. The authors have made a portion of their data available. The segmentation of the lesions appear accurate but there is no way to validate without the primary imaging data, etc. There is no validation of the method internally by the authors other than a relative neurosurgeon rating score, which is not a validated measure. The argument that this technique can help identify function is only partially accurate. Neurophysiologcial monitoring and awake technique remain pillars of clinical care because anatomy does not always equal function. Receptive speech centers are a classic example. We know that clinically they are not restricted to angular gyrus and supramarginal gyrus but can be represented broadly in the inferior parietal lobule and posterior temporal lobe in the dominant hemisphere.

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#2: No

Reviewer \#3: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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Author response to Decision Letter 1

16 Feb 2020

Dear Editor,

We have studied the valuable comments from you, the assistant editor and reviewers carefully, and tried our best to revise the manuscript. We have uploaded part of the patient data to verify the repeatability of our study.

The point to point responds to the reviewer's comments are listed as following:

Responds to the reviewer's comments:

Reviewer 3

Comment 1: The manuscript would benefit from revision by an English language editor.

Response: Thank you for your careful work. We have submitted the original manuscript to the English translation company for revision.

Comment 2: The authors have made a portion of their data available. The segmentation of the lesions appear accurate but there is no way to validate without the primary imaging data, etc.

Response: Thank you for your careful work. DICOM data is raw data, it contains the patient\'s privacy information. Therefore, we use dcm2nii software to transform DICOM data into "T1.nii" data, and remove the patient\'s privacy information. With the help of 3D Slicer，tumor was labeled and removed，the new data of "T1 without tumor. nii" is generated and can be loaded into Freesurfer software to segment the brain.

Comment 3: There is no validation of the method internally by the authors other than a relative neurosurgeon rating score, which is not a validated measure.

Response: Thank you for your advice. However, we are just trying to compare the difference of brain model that\'s been segmented by FreeSurfer software and traditional methods. The neurosurgeon rating score is the most direct and simple way to judge the pros and cons of the two models. In fact, the advantages of the former are obvious. Through literature review, there are similar evaluation methods, just like Karibe et al, in the early stage, used DWI to judge the damage degree of cerebral hemorrhage to corticospinal tract (CST), they also performed CST injury classification by visually observing the relationship between hematoma and CST. (Karibe H, Shimizu H, Tominaga T, et al. Diffusion-weighted magnetic resonance imaging in the early evaluation on of corticospinal tract injury to predict functional motor outcome in patients with deep intracerebral hemorrhage. J Neurosurg.2000;92(1):58-63.) Pandrangi et al. used patients\' subjective scores to prove that VR technology is more advantageous in communicating with patients. (Pandrangi VC, Gaston B, Appelbaum NP, Albuquerque FC, Jr., Levy MM, Larson RA. The application of virtual reality in patient education. Ann Vasc Surg. 2019;59: 184-189.)

Comment 4: The argument that this technique can help identify function is only partially accurate. Neurophysiologcial monitoring and awake technique remain pillars of clinical care because anatomy does not always equal function. Receptive speech centers are a classic example. We know that clinically they are not restricted to angular gyrus and supramarginal gyrus but can be represented broadly in the inferior parietal lobule and posterior temporal lobe in the dominant hemisphere.

Response: Thank you for your advice. This is a mistake in writing. We have changed

the summary that the methods we have provided can be used by surgeons as a cheap and easy way to identify the "real" relationship between the extracerebral intracranial lesion and adjacent brain tissue before surgery and improve preoperative planning in any unit. Our method can only provide anatomical segmentation of brain tissue according to different brain structure templates.
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PONE-D-19-26376R2

Dear Dr. dongdong,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at <https://www.editorialmanager.com/pone/>, click the \"Update My Information\" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.

With kind regards,

Jonathan H Sherman

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#3: All comments have been addressed

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#3: No

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#3: Yes

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#3: The article is written in more clearly. They have addressed most of the comments. They apparently cannot provide deidentified imaging data for all patients.

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#3: No

10.1371/journal.pone.0230754.r006

Acceptance letter

Sherman

Jonathan H

Academic Editor

© 2020 Jonathan H Sherman

2020

Jonathan H Sherman

This is an open access article distributed under the terms of the

Creative Commons Attribution License

, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

7 Apr 2020

PONE-D-19-26376R2

A New Simple Brain Segmentation Method for Extracerebral Intracranial Tumors

Dear Dr. Yang:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.
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